379 related articles for article (PubMed ID: 16965178)
21. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
[TBL] [Abstract][Full Text] [Related]
22. DEQOR: a web-based tool for the design and quality control of siRNAs.
Henschel A; Buchholz F; Habermann B
Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W113-20. PubMed ID: 15215362
[TBL] [Abstract][Full Text] [Related]
23. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.
Martinez J; Patkaniowska A; Urlaub H; Lührmann R; Tuschl T
Cell; 2002 Sep; 110(5):563-74. PubMed ID: 12230974
[TBL] [Abstract][Full Text] [Related]
24. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the RNA Interference Activity Using Central Mismatched siRNAs and Acyclic Threoninol Nucleic Acids (aTNA) Units.
Alagia A; Terrazas M; Eritja R
Molecules; 2015 Apr; 20(5):7602-19. PubMed ID: 25919280
[TBL] [Abstract][Full Text] [Related]
26. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
Ohnishi Y; Tokunaga K; Hohjoh H
Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
[TBL] [Abstract][Full Text] [Related]
28. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.
Birmingham A; Anderson EM; Reynolds A; Ilsley-Tyree D; Leake D; Fedorov Y; Baskerville S; Maksimova E; Robinson K; Karpilow J; Marshall WS; Khvorova A
Nat Methods; 2006 Mar; 3(3):199-204. PubMed ID: 16489337
[TBL] [Abstract][Full Text] [Related]
29. Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experiments.
Zagalak JA; Menzi M; Schmich F; Jahns H; Dogar AM; Wullschleger F; Towbin H; Hall J
RNA; 2015 Dec; 21(12):2132-42. PubMed ID: 26516083
[TBL] [Abstract][Full Text] [Related]
30. Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism.
Dykxhoorn DM; Schlehuber LD; London IM; Lieberman J
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5953-8. PubMed ID: 16585504
[TBL] [Abstract][Full Text] [Related]
31. Potential design rules and enzymatic synthesis of siRNAs.
Sioud M; Leirdal M
Methods Mol Biol; 2004; 252():457-69. PubMed ID: 15017071
[TBL] [Abstract][Full Text] [Related]
32. Short interfering RNA (siRNA) as a novel therapeutic.
Pushparaj PN; Melendez AJ
Clin Exp Pharmacol Physiol; 2006; 33(5-6):504-10. PubMed ID: 16700886
[TBL] [Abstract][Full Text] [Related]
33. sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database.
Shah JK; Garner HR; White MA; Shames DS; Minna JD
BMC Bioinformatics; 2007 May; 8():178. PubMed ID: 17540034
[TBL] [Abstract][Full Text] [Related]
34. In vivo application of an RNAi strategy for the selective suppression of a mutant allele.
Kubodera T; Yamada H; Anzai M; Ohira S; Yokota S; Hirai Y; Mochizuki H; Shimada T; Mitani T; Mizusawa H; Yokota T
Hum Gene Ther; 2011 Jan; 22(1):27-34. PubMed ID: 20649474
[TBL] [Abstract][Full Text] [Related]
35. Computational models with thermodynamic and composition features improve siRNA design.
Shabalina SA; Spiridonov AN; Ogurtsov AY
BMC Bioinformatics; 2006 Feb; 7():65. PubMed ID: 16472402
[TBL] [Abstract][Full Text] [Related]
36. siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells.
Li C; Liu Z; Yang F; Liu W; Wang D; Dong E; Wang Y; Wu CI; Lu X
Oncotarget; 2015 Aug; 6(25):21603-13. PubMed ID: 26057633
[TBL] [Abstract][Full Text] [Related]
37. Single base mismatches in the mRNA target site allow specific seed region-mediated off-target binding of siRNA targeting human coagulation factor 7.
Ravon M; Berrera M; Ebeling M; Certa U
RNA Biol; 2012 Jan; 9(1):87-97. PubMed ID: 22258146
[TBL] [Abstract][Full Text] [Related]
38. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
39. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.
Holen T; Amarzguioui M; Wiiger MT; Babaie E; Prydz H
Nucleic Acids Res; 2002 Apr; 30(8):1757-66. PubMed ID: 11937629
[TBL] [Abstract][Full Text] [Related]
40. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
